Try our Advanced Search for more refined results

Expert Analysis

FDA Is Evolving On New Chemical Entity Exclusivity

Law360, New York ( March 11, 2014, 10:03 AM EDT) -- Combination drugs are becoming increasingly important in treating chronic diseases such as heart disease, stroke, cancer, diabetes and arthritis, which are some of the most common, costly and preventable of all health problems. Patients living with many of these diseases are often prescribed multiple drugs to be taken on varying schedules, and this is where drug combinations are changing the treatment landscape. By offering multiple drugs in a single dose, fixed-combination drugs can improve patient compliance with treatment regimens and contribute to better patient outcomes....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!